APP and Alzheimer disease: In turn, Aβ peptides and APP activate glial cells (Dickson et al., 1993; Barger and Harmon, 1997), produce an enhanced release of pro-inflammatory mediators such as IL-1 and IFNγ in the brains of AD patients (Ho et al., 2005; Meager, 2004, 2005).